Conventus, as the economic organiser, is fully responsible for the sponsorship.

Technical workshop

BRCA im Wandel der Zeit – von der genetischen Beratung zur therapeutischen Konsequenz

Freitag, 08. März 2019 | 12:30 – 13:30 Uhr
Raum: SR 1 (150 pax) 

Vorsitz: Prof. Dr. med. Olaf Rieß, Tübingen
Begrüßung und Einleitung

BRCA-Diagnostik am Blut versus Tumor - welche Anforderungen stellt das Gendiagnostikgesetz
Dr. rer. nat. Simone Heidemann, Kiel

BRCA-Mutationen 2.0: Die klinische Relevanz bei gynäkologischen Tumoren
Prof. Dr. Marion Kiechle, München

Unübliche klinische Manifestation von Mutationen in Brustkrebsgenen
Prof. Dr. med. Olaf Rieß, Tübingen

Zusammenfassung und Ausblick

Die Veranstaltung richtet sich ausschließlich an Ärztinnen und Ärzte.
Eine Fortbildung von AstraZeneca

Power a New Future in Molecular Genomics

Achieve real savings with automated workflows and nanoscale reactions
Dr. rer. nat. Müge Akpinar (Field Application Specialist, Fluidigm)

Donnerstag, 07. März 2019

Genetic disease testing today and the future of Whole Genome Sequencing for Rare Disease

Anwendung des Clinical Exome Panels in der molekulargenetischen Routine-Diagnostik
Elisabeth Maurer, PhD
Dr. rer. nat. Sören Wenzel
Sektion für Humangenetik, Medizinische Universität Innsbruck, Peter-Mayr-Straße 1, 6020, Innsbruck, Österreich 

The evolution of genetic disease testing and the future of Whole Genome Sequencing for Rare Disease
Tim Watts, Clinical Marketing Manager, EMEA, Illumina

Whole Exome Sequencing has arrived in routine diagnostics
Donnerstag, 07. März 2019 | 12:00 – 13:00 Uhr

VarvisTM – a comprehensive software solution tailored for WES
Dr. Ben Liesfeld, CEO Limbus Medical Technologies GmbH

The Twist Exome as the ideal platform for routine diagnostics
Dr. Tina Han, Field Application Scientist, Twist Bioscience

Clinical examples of trio exome sequencing
Dr. Konrad Platzer, University of Leipzig Medical Center

New Tools for Clinical Applications

'Fish ‘n‘ tipps - workshop- machen sie mehr aus ihrem FISH'

Daniela Johannes, Field Application Specialist, and Igor Gerasimovski, Business Development Manager.

This lunchtime session focuses on how to get the most out of your FISH probes in your laboratory. Packed with useful information, find out how we can help to optimise your FISH testing to a high standard.

Our workshop will also include tips on result interpretation.

Characterizing CNV, indels and mutation linkage with 3-color Crystal Digital PCR

Sebastien Avizou (Application Specialist at Stilla Technologies)

Thursday, 7 March • Seminarraum 4

Gene and microRNA cardiotixicty identified in human cardiomyocytes

Dr. Harshal Nemade University of Cologne, Institute of Neurophysiology and Center for Molecular Medicine Cologne (CMMC)

Erfahrungen aus sieben Jahren Target-Sequencing mittels IonTorrent-Technologie – humangenetische Diagnostik im Spannungsfeld zwischen GWAS und EBM
Dr. Dalski, University Lübeck, Institute for Human Genetics

One-click, cartridge-based Sanger sequencing and fragment analysis – a demonstration of the new Applied Biosystems SeqStudio Genetic Analyzer
Dr. Andrea Töppel, Thermo Fisher Scientific

In this workshop, we discuss and demonstrate new and more established genetic analysis approaches for the discovery and verification of DNA vari-ants and gene expression changes that contribute to genetic diseases.  

Join us to see how to use microarrays to identify exon-level copy number variation across the genome in a single experiment; verify DNA variants within two hours without bioinformatics expertise; define trinucleotide repeat variation with a simple fragment analysis approach, and identify disease causing variants in your own laboratory, through gene panel based NGS. 

Twist Bioscience – Raising the Bar for NGS Target Enrichment
Freitag, 08. März 2019

12:30 – 12:40 Target Enrichment Solutions from Twist Bioscience - Product Overview and Key Features
Dr. Tina Han, Field Application Scientist, Twist Bioscience

12:40 – 13:05 Validation & Verification of the Twist Exome Workflow for Clinical Use
Dr. Jochen Seggewiß, Institut für Humangenetik, Universitätsklinikum Münster

13:05 – 13:30 Detection of Copy Number Variations - The Impact of Uniformity
Dr. Ben Liesfeld, CEO Limbus Medical Technologies GmbH